Literature DB >> 28905101

Transanal minimally invasive surgery for rectal polyps and selected malignant tumors: caution concerning intermediate-term functional results.

S H E M Clermonts1, Y T van Loon2, A H W Schiphorst2, D K Wasowicz2, D D E Zimmerman2.   

Abstract

PURPOSE: Transanal minimally invasive surgery (TAMIS) is gaining worldwide popularity as an alternative for the transanal endoscopic microsurgery (TEMS) method for the local excision of rectal polyps and selected neoplasms. Data on patient reported outcomes regarding short-term follow-up are scarce; data on functional outcomes for long-term follow-up is non-existent.
METHODS: We used the fecal incontinence severity index (FISI) to prospectively assess the fecal continence on the intermediate-term follow-up after TAMIS. The primary outcome measure is postoperative fecal continence. Secondary outcome measures are as follows: perioperative and intermediate-term morbidity.
RESULTS: Forty-two patients (m = 21:f = 21), median age 68.5 (range 34-94) years, were included in the analysis. In four patients (9.5%), postoperative complications occurred. The median follow-up was 36 months (range 24-48). Preoperative mean FISI score was 8.3 points. One year after TAMIS, mean FISI score was 5.4 points (p = 0.501). After 3 years of follow-up, mean FISI score was 10.1 points (p = 0.01). Fecal continence improved in 11 patients (26%). Continence decreased in 20 patients (47.6%) (mean FISI score 15.2 points, [range 3-31]).
CONCLUSIONS: This study found that the incidence of impaired fecal continence after TAMIS is substantial; however, the clinical significance of this deterioration seems minor. The present data is helpful in acquiring informed consent and emphasizes the need of proper patient information. Functional results seem to be comparable to results after TEMS. Furthermore, we confirmed TAMIS is safe and associated with low morbidity.

Entities:  

Keywords:  Anorectal function; Fecal incontinence; Fecal incontinence severity index; Rectal; TAMIS; Transanal endoscopic microsurgery; Transanal minimally invasive surgery

Mesh:

Year:  2017        PMID: 28905101     DOI: 10.1007/s00384-017-2893-6

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  43 in total

1.  Transanal endoscopic microsurgery excision: is anorectal function compromised?

Authors:  M L Kennedy; D Z Lubowski; D W King
Journal:  Dis Colon Rectum       Date:  2002-05       Impact factor: 4.585

2.  Influence of Parks' anal retractor on anal sphincter pressures.

Authors:  W F van Tets; J H Kuijpers; K Tran; R Mollen; H van Goor
Journal:  Dis Colon Rectum       Date:  1997-09       Impact factor: 4.585

3.  Patient and surgeon ranking of the severity of symptoms associated with fecal incontinence: the fecal incontinence severity index.

Authors:  T H Rockwood; J M Church; J W Fleshman; R L Kane; C Mavrantonis; A G Thorson; S D Wexner; D Bliss; A C Lowry
Journal:  Dis Colon Rectum       Date:  1999-12       Impact factor: 4.585

4.  Role of anal cushions in maintaining continence.

Authors:  C P Gibbons; E A Trowbridge; J J Bannister; N W Read
Journal:  Lancet       Date:  1986-04-19       Impact factor: 79.321

5.  [A system for a transanal endoscopic rectum operation].

Authors:  G Buess; F Hutterer; J Theiss; M Böbel; W Isselhard; H Pichlmaier
Journal:  Chirurg       Date:  1984-10       Impact factor: 0.955

6.  Transanal endoscopic microsurgery: impact on fecal incontinence and quality of life.

Authors:  Anneke Planting; P Terry Phang; Manoj J Raval; Carl J Brown
Journal:  Can J Surg       Date:  2013-08       Impact factor: 2.089

7.  Transanal endoscopic microsurgery: clinical and functional results.

Authors:  G Dafnis; L Påhlman; Y Raab; U-M Gustafsson; W Graf
Journal:  Colorectal Dis       Date:  2004-09       Impact factor: 3.788

8.  Technique of transanal endoscopic microsurgery.

Authors:  G Buess; K Kipfmüller; D Hack; R Grüssner; A Heintz; T Junginger
Journal:  Surg Endosc       Date:  1988       Impact factor: 4.584

9.  Age effects on internal anal sphincter thickness and diameter in nulliparous females.

Authors:  Markus Huebner; Rebecca U Margulies; Dee E Fenner; James A Ashton-Miller; Khalil N Bitar; John O L DeLancey
Journal:  Dis Colon Rectum       Date:  2007-09       Impact factor: 4.585

10.  Transanal minimally invasive surgery: initial experience and short-term functional results.

Authors:  Anandi H W Schiphorst; Barbara S Langenhoff; John Maring; Apollo Pronk; David D E Zimmerman
Journal:  Dis Colon Rectum       Date:  2014-08       Impact factor: 4.585

View more
  5 in total

1.  The effect of proctoring on the learning curve of transanal minimally invasive surgery for local excision of rectal neoplasms.

Authors:  S H E M Clermonts; Y T van Loon; J Stijns; H Pottel; D K Wasowicz; D D E Zimmerman
Journal:  Tech Coloproctol       Date:  2018-12-17       Impact factor: 3.781

2.  Systematic review of functional outcomes and quality of life after transanal endoscopic microsurgery and transanal minimally invasive surgery: a word of caution.

Authors:  Franco G Marinello; Anna Curell; Ingrid Tapiolas; Gianluca Pellino; Francesc Vallribera; Eloy Espin
Journal:  Int J Colorectal Dis       Date:  2019-11-25       Impact factor: 2.571

3.  Comparative Quality of Life in Patients Following Transanal Minimally Invasive Surgery and Healthy Control Subjects.

Authors:  Stefan H E M Clermonts; Yu-Ting van Loon; Dareczka K Wasowicz; Barbara S Langenhoff; David D E Zimmerman
Journal:  J Gastrointest Surg       Date:  2018-03-05       Impact factor: 3.452

4.  Salvage TME following TEM: a possible indication for TaTME.

Authors:  F Letarte; M Raval; A Karimuddin; P T Phang; C J Brown
Journal:  Tech Coloproctol       Date:  2018-05-04       Impact factor: 3.781

5.  Outcomes of completion total mesorectal excision are not compromised by prior transanal minimally invasive surgery.

Authors:  S H E M Clermonts; T Köeter; H Pottel; L P S Stassen; D K Wasowicz; D D E Zimmerman
Journal:  Colorectal Dis       Date:  2020-02-04       Impact factor: 3.788

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.